CCI vs STRO
Crown Castle (CCI) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. STRO currently screens at market cap $470.8M.
Not investment advice. Open the CCI and STRO stock pages for the full models.
Not investment advice.